• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday

    7/12/24 10:27:17 AM ET
    $ACHR
    $ANNX
    $AUR
    $BK
    Aerospace
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACHR alert in real time by email

    U.S. stocks were higher, with the Nasdaq Composite index gaining around 100 points on Friday.

    Shares of The Bank of New York Mellon Corporation (NYSE:BK) rose during Friday's session following better-than-expected quarterly financial results.

    The finance behemoth reported second-quarter adjusted earnings per share of $1.51, beating the street view of $1.43. Quarterly revenue of $4.597 billion, an increase of 2% year-over-year, surpassed the analyst consensus of $4.523 billion, according to data from Benzinga Pro.

    Bank of New York Mellon shares surged 4.3% to $64.12 on Friday.

    Here are some other big stocks recording gains in today’s session.

    • Lucid Group, Inc. (NASDAQ:LCID) shares jumped 17% to $3.9850. The stock may be up on continued strength after the company’s CEO recently said the co. will need to raise more money to grow, stating Saudi’s PIF is a ‘perfect’ long-term partner on EVs.
    • EVgo, Inc. (NASDAQ:EVGO) shares surged 14.2% to $3.8506. Benchmark analyst Michael Legg maintained EVgo with a Buy and raised the price target from $3 to $5.
    • QuantumScape Corporation (NASDAQ:QS) gained 12.2% to $7.92. QuantumScape recently announced it entered into an agreement with PowerCo to industrialize solid-state batteries.
    • Pacific Biosciences of California, Inc. (NASDAQ:PACB) gained 11.6% to $1.6750.
    • Archer Aviation Inc. (NYSE:ACHR) climbed 9.6% to $5.01. Archer Aviation announced it has signed a memorandum of understanding (MOU) with Southwest Airlines Company (NYSE:LUV) to develop operational plans for electric air taxi networks utilizing Archer's eVTOL aircraft at California airports.
    • Forward Air Corporation (NASDAQ:FWRD) gained 9.6% to $23.51.
    • Tyra Biosciences, Inc. (NASDAQ:TYRA) rose 9.1% to $20.69.
    • Annexon, Inc. (NASDAQ:ANNX) gained 9.1% to $5.97.
    • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) rose 8.8% to $8.37.
    • EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) climbed 8.7% to $10.77.
    • Aurora Innovation, Inc. (NASDAQ:AUR) gained 8.4% to $3.5889. Aurora Innovation, is expected to release second quarter 2024 results after the closing bell on July 31.
    • Intellia Therapeutics, Inc. (NASDAQ:NTLA) rose 8.4% to $26.72.
    • Rivian Automotive, Inc. (NASDAQ:RIVN) gained 7.4% to $18.01. Mizuho analyst Vijay Rakesh maintained Rivian Automotive with a Neutral and raised the price target from $11 to $15.
    • Hims & Hers Health, Inc. (NYSE:HIMS) rose 5.7% to $22.24.
    • e.l.f. Beauty, Inc. (NYSE:ELF) shares rose 4.6% to $218.54. Piper Sandler analyst Korinne Wolfmeyer maintained e.l.f. Beauty with an Overweight and raised the price target from $210 to $258.
    • Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) gained 3.8% to $6.63 after the company reported better-than-expected second-quarter sales and issued guidance.

    Now Read This:

    • NVIDIA To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Friday
    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $ANNX
    $AUR
    $BK

    CompanyDatePrice TargetRatingAnalyst
    Tyra Biosciences Inc.
    $TYRA
    4/15/2026$54.00Buy
    Guggenheim
    Tyra Biosciences Inc.
    $TYRA
    4/6/2026$50.00Buy
    Canaccord Genuity
    e.l.f. Beauty Inc.
    $ELF
    4/3/2026$68.00In-line
    Evercore ISI
    e.l.f. Beauty Inc.
    $ELF
    4/2/2026$68.00In-line
    Evercore ISI
    Rivian Automotive Inc.
    $RIVN
    4/1/2026$14.00Underperform → Neutral
    DA Davidson
    EVgo Inc.
    $EVGO
    3/25/2026Overweight → Neutral
    Analyst
    Lucid Group Inc.
    $LCID
    3/18/2026$17.00Buy
    Citigroup
    Rivian Automotive Inc.
    $RIVN
    3/10/2026$20.00Hold → Buy
    TD Cowen
    More analyst ratings

    $ACHR
    $ANNX
    $AUR
    $BK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on Tyra Biosciences with a new price target

    Guggenheim initiated coverage of Tyra Biosciences with a rating of Buy and set a new price target of $54.00

    4/15/26 8:10:45 AM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Tyra Biosciences with a new price target

    Canaccord Genuity initiated coverage of Tyra Biosciences with a rating of Buy and set a new price target of $50.00

    4/6/26 8:46:04 AM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Evercore ISI initiated coverage on e.l.f. Beauty with a new price target

    Evercore ISI initiated coverage of e.l.f. Beauty with a rating of In-line and set a new price target of $68.00

    4/3/26 10:44:59 AM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    $ACHR
    $ANNX
    $AUR
    $BK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Okupe Oluyemi

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    4/20/26 4:38:03 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Dable Habib J

    4 - Tyra Biosciences, Inc. (0001863127) (Issuer)

    4/20/26 4:31:02 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Dable Habib J

    3 - Tyra Biosciences, Inc. (0001863127) (Issuer)

    4/20/26 4:30:03 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $ANNX
    $AUR
    $BK
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Lucid Group Inc.

    SCHEDULE 13G - Lucid Group, Inc. (0001811210) (Subject)

    4/20/26 4:18:56 PM ET
    $LCID
    Auto Manufacturing
    Industrials

    SEC Form 6-K filed by Ericsson

    6-K - ERICSSON LM TELEPHONE CO (0000717826) (Filer)

    4/17/26 4:47:18 PM ET
    $ERIC
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form PRE 14A filed by Archer Aviation Inc.

    PRE 14A - Archer Aviation Inc. (0001824502) (Filer)

    4/17/26 4:45:46 PM ET
    $ACHR
    Aerospace
    Industrials

    $ACHR
    $ANNX
    $AUR
    $BK
    Leadership Updates

    Live Leadership Updates

    View All

    Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors

    -Seasoned biopharmaceutical leader brings deep commercial and strategic expertise to support TYRA's next phase of growth-CARLSBAD, Calif., April 17, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (NASDAQ:TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced the appointment of Habib Dable to its Board of Directors.Mr. Dable brings more than 30 years of leadership experience across the global biopharmaceutical industry, including deep expertise in building and scaling blockbuster franchises and guiding companies through transformative growth."As TY

    4/17/26 8:00:00 AM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lucid Names Global Industrial Leader Silvio Napoli as Next Chief Executive Officer to Accelerate Growth, Profitability and Value Creation

    Silvio Napoli, formerly Chairman and Chief Executive Officer of Schindler Group, to join Lucid as next Chief Executive OfficerInterim Chief Executive Officer Marc Winterhoff will continue as Chief Operating Officer upon Napoli assuming the roleNEWARK, Calif., April 14, 2026 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ:LCID), maker of the world's most advanced software-defined vehicles and technologies, today announced that Silvio Napoli will be Lucid's next Chief Executive Officer (CEO) and will join Lucid's Board of Directors. Mr. Napoli is currently based in Switzerland and will be relocating to the U.S. Interim Chief Executive Officer Marc Winterhoff will serve as Lucid's Chief Operating Off

    4/14/26 7:00:00 AM ET
    $LCID
    Auto Manufacturing
    Industrials

    Former U.S. Air Force Chief Scientist Dr. Mark Maybury Joins QuantumScape Strategic Advisory Board

    SAN JOSE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- QuantumScape Corporation (NASDAQ:QS), a global leader in next-generation solid-state lithium-metal battery technology, today announced Dr. Mark Maybury has joined its strategic advisory board. Dr. Maybury brings decades of leadership experience spanning defense, artificial intelligence, cybersecurity, digital transformation, and advanced manufacturing– further strengthening QS's push into additional markets. Dr. Maybury currently serves as Vice President of Commercialization, Engineering and Technology at Lockheed Martin, where he leads the transition of cutting-edge research into scalable products for commercial and defense application

    4/8/26 9:00:00 AM ET
    $QS
    Industrial Machinery/Components
    Miscellaneous

    $ACHR
    $ANNX
    $AUR
    $BK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Duker Jay S. bought $19,724 worth of shares (1,500 units at $13.15) (SEC Form 4)

    4 - EyePoint, Inc. (0001314102) (Issuer)

    3/16/26 4:12:55 PM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Carson William H. bought $45,360 worth of shares (8,000 units at $5.67), increasing direct ownership by 15% to 62,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    3/12/26 4:31:34 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Flatley Jay T bought $25,281 worth of shares (1,830 units at $13.81) and sold $11,775 worth of shares (580 units at $20.30), increasing direct ownership by 0.78% to 162,070 units (SEC Form 4)

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    3/5/26 5:10:12 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $ACHR
    $ANNX
    $AUR
    $BK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors

    -Seasoned biopharmaceutical leader brings deep commercial and strategic expertise to support TYRA's next phase of growth-CARLSBAD, Calif., April 17, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (NASDAQ:TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced the appointment of Habib Dable to its Board of Directors.Mr. Dable brings more than 30 years of leadership experience across the global biopharmaceutical industry, including deep expertise in building and scaling blockbuster franchises and guiding companies through transformative growth."As TY

    4/17/26 8:00:00 AM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SOUTHWEST AIRLINES TO DISCUSS FIRST QUARTER 2026 FINANCIAL RESULTS ON APRIL 23, 2026

    DALLAS, April 16, 2026 /PRNewswire/ -- Southwest Airlines Co. (NYSE:LUV) invites you to listen to a live webcast of its first quarter 2026 financial results. Details are as follows: When:             Thursday, April 23, 2026, at 10:00 AM Eastern TimeWho:              Bob Jordan, President, Chief Executive Officer, and Vice Chairman of the Board of DirectorsAndrew Watterson, Chief Operating OfficerTom Doxey, Executive Vice President and Chief Financial OfficerWeb Address:  http://www.southwestairlinesinvestorrelations.com/To access the live audio webcast and subsequent replay, click on the link above, or go to www.southwest.com and click on "Investor Relations" under the "About Southwest" men

    4/16/26 5:27:00 PM ET
    $LUV
    Air Freight/Delivery Services
    Consumer Discretionary

    PacBio to Report First Quarter 2026 Financial Results on May 7, 2026

    MENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). The call will be webcast and may be accessed on PacBio's website at https://investor.pacificbiosciences.com/. Date: Thursday, May 7, 2026, at 4:30 p.m. ET (1:30 p.m. PT)Listen live via internet or replay: https://investor.pacificbiosciences.com/ Toll-free: 1-888-349-0136 International: 1-412-317-0459 About PacBio PacBio (NASDAQ:PACB) is a premier life science technology company that designs, develops, and manufactures a

    4/16/26 4:05:00 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ACHR
    $ANNX
    $AUR
    $BK
    Financials

    Live finance-specific insights

    View All

    PacBio to Report First Quarter 2026 Financial Results on May 7, 2026

    MENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). The call will be webcast and may be accessed on PacBio's website at https://investor.pacificbiosciences.com/. Date: Thursday, May 7, 2026, at 4:30 p.m. ET (1:30 p.m. PT)Listen live via internet or replay: https://investor.pacificbiosciences.com/ Toll-free: 1-888-349-0136 International: 1-412-317-0459 About PacBio PacBio (NASDAQ:PACB) is a premier life science technology company that designs, develops, and manufactures a

    4/16/26 4:05:00 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    BNY Declares Dividends

    NEW YORK, April 16, 2026 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY") (NYSE:BK), a global financial services company, today announced that its Board of Directors declared dividends on its common and preferred stock as follows: Common – a quarterly common stock dividend of $0.53 per share, payable on May 8, 2026 to shareholders of record as of the close of business on April 27, 2026.Preferred – the following dividends for the noncumulative perpetual preferred stock, liquidation preference $100,000 per share, for the dividend period ending in June 2026, in each

    4/16/26 6:35:00 AM ET
    $BK
    Major Banks
    Finance

    BNY Reports First Quarter 2026 Results

    NEW YORK, April 16, 2026 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY") (NYSE:BK), a global financial services company, has reported financial results for the first quarter 2026. The company's earnings release along with the quarterly update presentation and other earnings-related documents are available at www.bny.com/investorrelations. Management will host a conference call and simultaneous live audio webcast at 11:00 a.m. ET today. This conference call and audio webcast will include forward-looking statements and may include other material information. Confer

    4/16/26 6:34:00 AM ET
    $BK
    Major Banks
    Finance

    $ACHR
    $ANNX
    $AUR
    $BK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Tyra Biosciences Inc.

    SC 13D/A - Tyra Biosciences, Inc. (0001863127) (Subject)

    12/6/24 9:30:49 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Pacific Biosciences of California Inc.

    SC 13G - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (0001299130) (Subject)

    11/26/24 8:27:01 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13D/A filed by Tyra Biosciences Inc.

    SC 13D/A - Tyra Biosciences, Inc. (0001863127) (Subject)

    11/19/24 9:31:34 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care